Approval of obinutuzumab as a breakthrough therapy for chronic lymphocytic leukemia

Clinical advances in hematology & oncology : H&O

Volumn 11, Issue 12, 2013, Pages 809-810

  Small, Stacey ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; OBINUTUZUMAB;

DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HUMAN; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; UNITED STATES;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; DRUG APPROVAL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84925549065     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)